Response to proposed research to reverse brain death: more than regulatory failure.
Indian J Med Ethics
;
2016 Jul-Sept; 1 (3): 134-137
Artículo
en Inglés
| IMSEAR
| ID: sea-180251
ABSTRACT
In early May 2016, reports of a bizarre study to attempt a reversal of brain death made the headlines, but there was not even a squeak from the authorities. The “Reanima Project” is a collaboration between an Indian surgeon, Himanshu Bansal, and a US-based biotech company, Bioquark Inc. The research will be conducted by Bansal’s own biotech company, Revita Life Sciences, at his Anupam hospital in Rudrapur, a city in Uttarakhand state.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Idioma:
Inglés
Revista:
Indian J Med Ethics
Asunto de la revista:
Ethics
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS